InvestorsHub Logo

HappyLibrarian

05/15/22 9:08 AM

#473437 RE: Judge Smails 40 #473429

To be clear releasing and then shutting up was never what those opposed to management’s now abandoned plan asked for so as I’ve noted we get the worst of both worlds from what management decided to do do in October 2020 and what they originally planned to do in September 2020

We have the negatives of an unprotected (by the journal) data release and none of the positives (hands free on public and investor relations).

Sadly if I had come up with my most pessimistic scenario for data release before last Tuesday this would not have been it.

We have to remember that everyone was expecting a PR to drop that Morning and reference until a journal - until it didn’t.

trocprofit

05/15/22 1:34 PM

#473561 RE: Judge Smails 40 #473429

This has been the most mismanaged, poorly thought out strategy I have ever seen. You wait 19 months, creating even more doubt, then release topline without the Journal or anything from the company to talk rave about the next standard of care in GBM and possibly other cancers. It's the only trial to succeed in 20+ years and we have heard ZERO while the Fud's and AF's of the world pile on and control the narrative. Lawsuits coming, IMO.